We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $24B
1-Year Est. Return 37.67%
This Fund
S&P 500
This Quarter Est. Return
+34.77%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
AUM
$1.54B
AUM Growth
-$138M
Cap. Flow
-$300M
Cap. Flow %
-19.47%
Top 10 Hldgs %
9.99%
Holding
2,498
New
653
Increased
404
Reduced
598
Closed
777

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$2.77M
2
CI icon
Cigna
CI
+$2.57M
3
META icon
Meta Platforms (Facebook)
META
+$2.48M
4
BIDU icon
Baidu
BIDU
+$2.2M
5
BHC icon
Bausch Health
BHC
+$2.09M

Sector Composition

Rank Sector Weight
1 Healthcare 4.98%
2 Technology 4.63%
3 Consumer Discretionary 3.8%
4 Industrials 1.77%
5 Financials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMZN icon
626
Amazon
AMZN
$2.49T
$556K 0.04%
6,020
-1,820
-23% -$161K
PAYC icon
627
PUT
Paycom
PAYC
$7.23B
$556K 0.04%
2,100
-400
-16% -$94.7K
NTES icon
628
NetEase
NTES
$79.3B
$555K 0.04%
9,050
+7,750
+596% +$454K
SWIR
629
DELISTED
Sierra Wireless
SWIR
$555K 0.04%
+58,009
New +$564K
HRB icon
630
CALL
H&R Block
HRB
$5.4B
$554K 0.04%
23,600
-40,500
-63% -$972K
SSNC icon
631
PUT
SS&C Technologies
SSNC
$18.3B
$553K 0.04%
+9,000
New +$505K
EXC icon
632
CALL
Exelon
EXC
$48.4B
$552K 0.04%
16,964
-39,537
-70% -$1.28M
VYX icon
633
CALL
NCR Voyix
VYX
$1.14B
$552K 0.04%
+25,591
New +$498K
PVG
634
CALL
DELISTED
PRETIUM RESOURCES INC.
PVG
$552K 0.04%
49,600
-4,600
-8% -$48.9K
CRL icon
635
CALL
Charles River Laboratories
CRL
$10.8B
$550K 0.04%
3,600
-7,400
-67% -$1.02M
ELF icon
636
CALL
e.l.f. Beauty
ELF
$4.88B
$550K 0.04%
+34,100
New +$567K
ARNA
637
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
$550K 0.04%
12,100
+6,400
+112% +$303K
AU icon
638
PUT
AngloGold Ashanti
AU
$40.6B
$547K 0.04%
24,500
-35,600
-59% -$717K
SCOR icon
639
Comscore
SCOR
$106M
$544K 0.04%
5,512
+4,962
+902% +$339K
ANAB icon
640
PUT
AnaptysBio
ANAB
$1.62B
$540K 0.04%
+33,200
New +$785K
BCOV
641
CALL
DELISTED
Brightcove, Inc.
BCOV
$540K 0.04%
62,100
-11,400
-16% -$107K
SFM icon
642
CALL
Sprouts Farmers Market
SFM
$7.23B
$538K 0.03%
27,800
-75,200
-73% -$1.46M
PCRX icon
643
PUT
Pacira BioSciences
PCRX
$1.05B
$530K 0.03%
+11,700
New +$497K
BPMC
644
PUT
DELISTED
Blueprint Medicines
BPMC
$529K 0.03%
+6,600
New +$494K
AXGN icon
645
CALL
Axogen
AXGN
$2.18B
$528K 0.03%
29,500
-15,500
-34% -$229K
TGT icon
646
PUT
Target
TGT
$63.7B
$526K 0.03%
4,100
-20,500
-83% -$2.41M
APXTU
647
DELISTED
Apex Technology Acquisition Corporation Unit
APXTU
$524K 0.03%
50,000
TSCO icon
648
CALL
Tractor Supply
TSCO
$16.8B
$523K 0.03%
+28,000
New +$531K
STT icon
649
PUT
State Street
STT
$50.3B
$522K 0.03%
6,600
+400
+6% +$28.2K
TEX icon
650
CALL
Terex
TEX
$7.81B
$521K 0.03%
17,500
+12,300
+237% +$346K

Similar funds

Walleye Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Walleye Capital held 2,498 positions worth $1.54B, down 8.2% from $1.68B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Walleye Capital withdrew a net $300M in Q4 2019, closing 777 positions and reducing 598 holdings. Its most notable exit was Cigna, an estimated $2.57M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 5% of assets, up from 1.9% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Walleye Capital opened a new position in Cypress Semiconductor worth $17M.

  • Walleye Capital's largest Q4 2019 buy was Cypress Semiconductor: 727,918 shares worth $17M.
  • Walleye Capital added most to Acacia Communications Inc in Q4 2019, an estimated $8.45M increase.
  • Walleye Capital's biggest Q4 2019 reduction was Humana, cutting an estimated $2.77M.
  • Walleye Capital fully exited Cigna in Q4 2019, selling an estimated $2.57M.
  • Walleye Capital's ten largest holdings make up 10% of its $1.54B portfolio in Q4 2019.
  • Walleye Capital opened 653 new positions and closed 777 in Q4 2019.
  • Walleye Capital's portfolio value fell 8.2% quarter-over-quarter to $1.54B.

Based on Walleye Capital's 13F filing for Q4 2019, filed 14 Feb 2020.